FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ron Gansevoort

Research Profile

Disorders

Physiology

Glomerular Filtration Rate

Concepts & Ideas

Geographic Areas

Netherlands

Anatomy

Kidneys

Chemicals & Drugs

Procedures

Mass Screening

Co-author Network

Publications

TOP 3
Michel M Joosten; Jenny E Kootstra-Ros; Kenneth J Mukamal; gerjan navis; Stephan J L Bakker; Edith J M Feskens; Ron T Gansevoort; Johanna M Geleijnse
Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study.
Solmaz Assa; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Anneke C Muller Kobold; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients.
Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ron Gansevoort (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michel M Joosten; Jenny E Kootstra-Ros; Kenneth J Mukamal; gerjan navis; Stephan J L Bakker; Edith J M Feskens; Ron T Gansevoort; Johanna M Geleijnse
Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study.
Hypertension 2013;61(6):1161-7.
2013: Solmaz Assa; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Anneke C Muller Kobold; Adriaan A Voors; Ralf Westerhuis; Casper F M Franssen
Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients.
Clinical research in cardiology : official journal of the German Cardiac Society 2013;102(6):439-45.
2013: Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European heart journal 2013;34(19):1424-31.
2013: Merel E Hellemons; Hiddo J Lambers Heerspink; Dick de Zeeuw; Ron T Gansevoort; Stephan J L Bakker
High-sensitivity troponin T predicts worsening of albuminuria in hypertension; results of a nested case-control study with confirmation in diabetes.
Journal of hypertension 2013;31(4):805-12.
2013: Vicente E Torres; Ron T Gansevoort; Frank S Czerwiec
Tolvaptan in autosomal dominant polycystic kidney disease.
The New England journal of medicine 2013;368(13):1259.
2013: Niek Verweij; Hongjuan Yu; Wiek H van Gilst; Dirk J van Veldhuisen; Folkert W Asselbergs; Stephan J L Bakker; Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Hasan Mahmud; Irene Mateo Leach; Patricia B Munroe; Herman H W Silljé; Joachim Struck; Pim van der Harst
Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1.
Hypertension 2013;61(3):602-8.
2013: Michelle C Odden; Mark J Sarnak; Suzanne Satterfield; Stephan J L Bakker; Linda F Fried; Ron T Gansevoort; Tamara B Harris; Ronit Katz; Anne B Newman; David Siscovick; Ira B Tager; Michael G Shlipak
Hypertension and low HDL cholesterol were associated with reduced kidney function across the age spectrum: a collaborative study.
Annals of epidemiology 2013;23(3):106-11.
2013: Wendy E Boertien; James E Bost; Michael F Flessner; Ron T Gansevoort; Jie Li; Esther Meijer; Joachim Struck; Vicente E Torres
Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013;61(3):420-9.
2013: S S Roscioni; Peter Rossing; Petra Zürbig; S J L Bakker; Dick De Zeeuw; Ron T Gansevoort; Merel Elise Hellemons; Maria Lajer; H Mischak; Frederik Persson; H Reinhard; H J Lambers Heerspink
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus.
Diabetologia 2013;56(2):259-67.
2013: Katarina Mirković; Ferdau L Nauta; gerjan navis; Maartje C J Slagman; Jacob Van Den Born; Carolina R C Doorenbos; Ron T Gansevoort; Andrea B Kramer; Hiddo J Lambers Heerspink; Wendy A Dam; Martin H de Borst
Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis.
PloS one 2013;8(2):e55887.
2013: Paul J W H Kappelle; Bruce H R Wolffenbuttel; Robin P F Dullaart; Ron T Gansevoort; Hans J Hillege
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Journal of clinical lipidology 2013;7(1):56-64.
2012: Vicente E Torres; Arlene B Chapman; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Holly B Krasa; John Ouyang; Ronald D Perrone
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
The New England journal of medicine 2012;367(25):2407-18.
2012: Stein Hallan; Areef Ishani; Nanne Kleefstra; Adeera Levin; Bakhtawar K Mahmoodi; Kunihiro Matsushita; David Naimark; Paul Roderick; Yingying Sang; Marcello Tonelli; Chi-Pang Wen; Jack F M Wetzels; Brad C Astor; Corri Black; Josef Coresh; Ron T Gansevoort
Age and association of kidney measures with mortality and end-stage renal disease.
JAMA : the journal of the American Medical Association 2012;308(22):2349-60.
2012: Paul A Smink; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Hiddo J Lambers Heerspink; Dick De Zeeuw
Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(5):804-11.
2012: Merel E Hellemons; Robert H Henning; Hiddo J Lambers-Heerspink; Magdalena Mazagova; Stephan J L Bakker; Dick de Zeeuw; Ron T Gansevoort; Leo E Deelman
Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes.
Diabetes care 2012;35(11):2340-6.
2012: Wendy E Boertien; Martijn H Breuning; Paul E de Jong; Esther Meijer; Dorien J M Peters; Ton J Rabelink; Joachim Struck; Marjan A van Dijk; Debbie Zittema; Stephan J L Bakker; Ron T Gansevoort
Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(11):4131-7.
2012: Bakhtawar K Mahmoodi; Kunihiro Matsushita; Karina Meijer; Inger Anne Naess; Yingying Sang; Nic J G M Veeger; Brad C Astor; Sigrid K Brækkan; Ellen E Brodin; Suzanne C Cannegieter; Josef Coresh; Aaron R Folsom; Ron T Gansevoort; Stein I Hallan; Jens Hammerstrøm; John-Bjarne Hansen; Pamela L Lutsey; Mary Cushman
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.
Circulation 2012;126(16):1964-71.
2012: Ali Abbasi; Joline W J Beulens; Eva Corpeleijn; Paul E de Jong; Rijk O B Gans; Ron T Gansevoort; Hans L Hillege; gerjan navis; Linda M Peelen; Douwe Postmus; Janin Schulte; Ronald P Stolk; Joachim Struck; Pim van der Harst; Stephan J L Bakker
Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
Journal of the American Heart Association 2012;1(5):e002956.
2012: Inge M van Schouwenburg; Margaretha M Visser; Ron T Gansevoort; Hanneke C Kluin-Nelemans; Willem M Lijfering; Bakhtawar K Mahmoodi; Nic J G M Veeger
Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study.
British journal of haematology 2012;159(2):216-22.
2012: Frank P Brouwers; Rudolf A de Boer; Paul E de Jong; Dick de Zeeuw; Rijk O Gans; Ron T Gansevoort; Hans L Hillege; Joachim Struck; Pim van der Harst; Wiek H van Gilst; Stephan J Bakker
Influence of age on the prognostic value of mid-regional pro-adrenomedullin in the general population.
Heart (British Cardiac Society) 2012;98(18):1348-53.
2012: Rudolf A de Boer; Ron T Gansevoort; Stephan J L Bakker; Hasan Mahmud; Nicolas F Schroten; Mariusz K Szymanski; Pim van der Harst; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege
Plasma renin and outcome in the community: data from PREVEND.
European heart journal 2012;33(18):2351-9.
2012: Lieneke Scheven; L Joost van Pelt; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort; Hans L Hillege; Jenny E Kootstra; Hiddo J Lambers Heerspink
High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate.
European heart journal 2012;33(18):2272-81.
2012: Wendy E Boertien; Esther Meijer; Ron T Gansevoort
Urinary biomarkers in autosomal dominant polycystic kidney disease: is there no prognostic value?
Kidney international 2012;82(3):361.
2012: Gerbrand J Izaks; gerjan navis; Joris P J Slaets; Aafke M van der Knaap; Ron T Gansevoort; Robin P F Dullaart
Cholesteryl Ester Transfer Protein (CETP) genotype and cognitive function in persons aged 35 years or older.
Neurobiology of aging 2012;33(8):1851.e7-16.
2012: A Abbasi; Eva Corpeleijn; R O B Gans; Ron T Gansevoort; Hans L Hillege; E Meijer; gerjan navis; D Postmus; R P Stolk; Joachim Struck; S J L Bakker
Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
Diabetologia 2012;55(7):1963-70.
2012: James P Corsetti; Ron T Gansevoort; gerjan navis; Charles E Sparks; Stephan J L Bakker; Robin P F Dullaart
Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.
Metabolism: clinical and experimental 2012;61(7):996-1002.
2012: John P Forman; Stephan J L Bakker; Gary C Curhan; Paul E de Jong; Lieneke Scheven; Ron T Gansevoort
Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension.
Circulation 2012;125(25):3108-16.
2012: Debbie Zittema; Esther Meijer; André P van Beek; Wendy E Boertien; Paul E de Jong; Robin P F Dullaart; Casper F M Franssen; Ron T Gansevoort
Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(6):906-13.
2012: Kunihiro Matsushita; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Mark Woodward; Josef Coresh; Jonathan R Emberson; Ron T Gansevoort; Brenda R Hemmelgarn; Tazeen H Jafar; Sun Ha Jee; Andrew S Levey; Bakhtawar K Mahmoodi
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.
JAMA : the journal of the American Medical Association 2012;307(18):1941-51.
2012: Marjan Alssema; Stephan J L Bakker; Ron T Gansevoort; Martijn W Heymans; Hans L Hillege; Albert Hofman; Rachel S Newson; Giel Nijpels; Coen D A Stehouwer; Jacqueline C M Witteman; Jacqueline M Dekker
One risk assessment tool for cardiovascular disease, type 2 diabetes, and chronic kidney disease.
Diabetes care 2012;35(4):741-8.
2012: Ferdau L Nauta; Wim van Oeveren; Hiddo Lambers Heerspink; Stephan J L Bakker; Henk Bilo; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Effect of frozen storage on urinary concentration of kidney damage markers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(4):586-9.
2012: Inge M van Schouwenburg; Nic J G M Veeger; Ron T Gansevoort; Hanneke C Kluin-Nelemans; Bakhtawar K Mahmoodi; Karina Meijer
Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study.
British journal of haematology 2012;156(5):667-71.
2012: Annemieke Visser; Paul E de Jong; Johan De Meester; Geke J Dijkstra; Ron T Gansevoort; Andries J Hoitsma; Gerbrand J Izaks; Kitty J Jager; Marlies Noordzij; Sijmen A Reijneveld; Wim Van Biesen; Casper F M Franssen
Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(2):803-9.
2012: Ali Abbasi; Stephan J L Bakker; Eva Corpeleijn; Rijk O B Gans; Ron T Gansevoort; gerjan navis; Linda M Peelen; Annemieke M W Spijkerman; Ronald P Stolk; Daphne L van der A; Yvonne T van der Schouw; Joline W J Beulens
Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.
PloS one 2012;7(12):e51496.
2012: Rudolf A de Boer; Lude Franke; Ron T Gansevoort; Irene Mateo Leach; Anneke C Muller Kobold; Wiek H van Gilst; Dirk J van Veldhuisen; Niek Verweij; Harm-Jan Westra; Stephan J L Bakker; Pim van der Harst
A genome-wide association study of circulating galectin-3.
PloS one 2012;7(10):e47385.
2012: Martin H de Borst; Ron T Gansevoort; Gozewijn D Laverman; Ferdau L Nauta; Liffert Vogt; gerjan navis
Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.
PloS one 2012;7(5):e37957.
2012: Ali Abbasi; Joline W J Beulens; Eva Corpeleijn; Paul E de Jong; Rijk O B Gans; Ron T Gansevoort; Hans L Hillege; Bernd Kowall; Christine Meisinger; gerjan navis; Linda M Peelen; Wolfgang Rathmann; Ronald P Stolk; Stephan J L Bakker
External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study.
European journal of epidemiology 2012;27(1):47-52.
2012: Annemieke Visser; Paul E de Jong; Geke J Dijkstra; Casper F M Franssen; Gerbrand J Izaks; Kitty J Jager; Sijmen A Reijneveld; Patricia Sunaert; Wim Van Biesen; Ron T Gansevoort
Exploration of the difference in incidence of renal replacement therapy in elderly patients in Flanders and the Netherlands--a comparison of referral policy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(1):338-44.
2011: Ali Abbasi; Eva Corpeleijn; P E de Jong; R O B Gans; Ron T Gansevoort; Hans L Hillege; gerjan navis; D Postmus; R P Stolk; Joachim Struck; S J L Bakker
Plasma procalcitonin and risk of type 2 diabetes in the general population.
Diabetologia 2011;54(9):2463-5.
2011: Deidra Crews; Ron T Gansevoort; L. Boulware; Bernard Jaar
Albuminuria: is it time to screen the general population?
Advances in chronic kidney disease 2011;18(4):249-57.
2011: Nynke Halbesma; Martijn W Heymans; Desiree F Jansen; Ronald P Stolk; Paul E de Jong; Ron T Gansevoort
Development and validation of a general population renal risk score.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(7):1731-8.
2011: Ron T Gansevoort; Andrew S Levey; Kunihiro Matsushita; Marije van der Velde; Mark Woodward; Brad C Astor; Josef Coresh; Paul E de Jong
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Kidney international 2011;80(1):93-104.
2011: Andrew S Levey; Kunihiro Matsushita; Meguid El Nahas; Ron T Gansevoort; Bertram L Kasiske; Brad C Astor; Josef Coresh; Paul E de Jong; Kai-Uwe Eckardt
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
Kidney international 2011;80(1):17-28.
2011: Frank P Brouwers; Folkert Asselbergs; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Dirk J van Veldhuisen; Wiek H van Gilst
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
American heart journal 2011;161(6):1171-8.
2011: Hanneke Joosten; Joris P J Slaets; Sipke T Visser; Henk J G Bilo; Paul E de Jong; Gerbrand J Izaks; Ron T Gansevoort
Association of cognitive function with albuminuria and eGFR in the general population.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(6):1400-9.
2011: Ferdau L Nauta; Stephan J L Bakker; Wim van Oeveren; gerjan navis; Jaap J Homan van der Heide; Harry van Goor; Paul E de Jong; Ron T Gansevoort
Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(5):733-43.
2011: Wouter N Leonhard; Annemieke van der Wal; Zlata Novalic; Steven J Kunnen; Ron T Gansevoort; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
American journal of physiology. Renal physiology 2011;300(5):F1193-202.
2011: Vicente E Torres; Esther Meijer; Kyongtae T Bae; Arlene B Chapman; Olivier Devuyst; Ron T Gansevoort; Jared J Grantham; Eiji Higashihara; Ronald D Perrone; Holly B Krasa; John J Ouyang; Frank S Czerwiec
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(5):692-9.
2011: Ferdau L Nauta; Wendy E Boertien; Stephan J L Bakker; Harry van Goor; Wim van Oeveren; Paul E de Jong; Henk Bilo; Ron T Gansevoort
Glomerular and tubular damage markers are elevated in patients with diabetes.
Diabetes care 2011;34(4):975-81.
2011: James P Corsetti; Ron T Gansevoort; gerjan navis; Charles E Sparks; Robin P F Dullaart
LPL polymorphism (D9N) predicts cardiovascular disease risk directly and through interaction with CETP polymorphism (TaqIB) in women with high HDL cholesterol and CRP.
Atherosclerosis 2011;214(2):373-6.
2011: Esther Meijer; Stephan J L Bakker; Eric J van der Jagt; gerjan navis; Paul E de Jong; Joachim Struck; Ron T Gansevoort
Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(2):361-8.
2011: Gerbrand J Izaks; gerjan navis; Robin P F Dullaart; Ron T Gansevoort; Aafke M van der Knaap; Joris P J Slaets
The association of APOE genotype with cognitive function in persons aged 35 years or older.
PloS one 2011;6(11):e27415.
2011: E Meijer; R Zietse; W E Boertien; Ron T Gansevoort
Potential deleterious effects of vasopressin in chronic kidney disease and particularly autosomal dominant polycystic kidney disease.
Kidney & blood pressure research 2011;34(4):235-44.
2011: Gerbrand J Izaks; Hanneke Joosten; Janneke Koerts; Ron T Gansevoort; Joris P Slaets
Reference data for the Ruff Figural Fluency Test stratified by age and educational level.
PloS one 2011;6(2):e17045.
2011: Paul E de Jong; Stephan J L Bakker; Ron T Gansevoort
What to measure-albuminuria or total proteinuria?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2011;57(1):1-2.
2011: Paul E de Jong; Ron T Gansevoort
Is cystatin C the answer to detecting progression in CKD?
Journal of the American Society of Nephrology : JASN 2011;22(1):9-11.
2010: Esther Meijer; Wendy E Boertien; Ferdau L Nauta; Stephan J L Bakker; Wim van Oeveren; Mieneke Rook; Eric J van der Jagt; Harry van Goor; Dorien J M Peters; gerjan navis; Paul E de Jong; Ron T Gansevoort
Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;56(5):883-95.
2010: Ron T Gansevoort; Ferdau L Nauta; Stephan J L Bakker
Albuminuria: all you need to predict outcomes in chronic kidney disease?
Current opinion in nephrology and hypertension 2010;19(6):513-8.
2010: Marije van der Velde; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Influence of age and measure of eGFR on the association between renal function and cardiovascular events.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(11):2053-9.
2010: Akin Özyilmaz; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Selection on albuminuria enhances the efficacy of screening for cardiovascular risk factors.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(11):3560-8.
2010: Ali Abbasi; Eva Corpeleijn; Douwe Postmus; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Joachim Struck; Hans L Hillege; Ronald P Stolk; gerjan navis; Stephan J L Bakker
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2010;95(9):E26-31.
2010: Hiddo J Lambers Heerspink; Ron T Gansevoort; Barry M Brenner; Mark E Cooper; Hans-Henrik Parving; Shahnaz Shahinfar; Dick De Zeeuw
Comparison of different measures of urinary protein excretion for prediction of renal events.
Journal of the American Society of Nephrology : JASN 2010;21(8):1355-60.
2010: Jan A Krikken; Ron T Gansevoort; Robin P F Dullaart
Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.
Journal of lipid research 2010;51(7):1982-90.
2010: Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Lancet 2010;375(9731):2073-81.
2010: Cornelis Boersma; Ron T Gansevoort; Petros Pechlivanoglou; Sipke T Visser; Flip F J van Toly; Lolkje T W de Jong van den Berg; Paul E de Jong; Maarten J Postma
Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
Clinical therapeutics 2010;32(6):1103-21.
2010: Esther Meijer; Mieneke Rook; Hilde Tent; gerjan navis; Eric J van der Jagt; Paul E de Jong; Ron T Gansevoort
Early renal abnormalities in autosomal dominant polycystic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(6):1091-8.
2010: James P Corsetti; Ron T Gansevoort; Charles E Sparks; Robin P F Dullaart
Inflammation reduces HDL protection against primary cardiac risk.
European journal of clinical investigation 2010;40(6):483-9.
2010: Nynke Halbesma; Desiree F Jansen; Ronald P Stolk; Paul E de Jong; Ron T Gansevoort
Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(6):1846-53.
2010: Esther Meijer; Paul E de Jong; Ron T Gansevoort
Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake?
Kidney international 2010;77(9):832-3.
2010: Ron T Gansevoort; Paul E de Jong
Challenges for the present CKD classification system.
Current opinion in nephrology and hypertension 2010;19(3):308-14.
2010: Paul E de Jong; Ron T Gansevoort
Albuminuria in non-primary renal disease: risk marker rather than risk factor.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(3):656-8.
2010: Michelle C Odden; Ira B Tager; Ron T Gansevoort; Stephan J L Bakker; Ronit Katz; Linda F Fried; Anne B Newman; Robert B Canada; Tamara Harris; Mark J Sarnak; David Siscovick; Michael G Shlipak
Age and cystatin C in healthy adults: a collaborative study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(2):463-9.
2010: Gerard C M Linssen; Stephan J L Bakker; Adriaan Voors; Ron T Gansevoort; Hans L Hillege; Paul E de Jong; Dirk J van Veldhuisen; Rijk O B Gans; Dick De Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
European heart journal 2010;31(1):120-7.
2010: Esther Meijer; Stephan J L Bakker; Nynke Halbesma; Paul E de Jong; Joachim Struck; Ron T Gansevoort
Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort.
Kidney international 2010;77(1):29-36.
2009: Leendert H Oterdoom; Ron T Gansevoort; Jan Schouten; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population.
Atherosclerosis 2009;207(2):534-40.
2009: Annemieke Visser; Geke J Dijkstra; Daphne Kuiper; Paul E de Jong; Casper F M Franssen; Ron T Gansevoort; Gerbrand J Izaks; Kitty J Jager; Sijmen A Reijneveld
Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease.
Journal of nephrology 2009;22(6):794-9.
2009: Esther Meijer; Stephan J L Bakker; Paul E de Jong; Jaap J Homan van der Heide; Willem J van Son; Joachim Struck; Simon P M Lems; Ron T Gansevoort
Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients.
Transplantation 2009;88(4):561-7.
2009: Nynke Halbesma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
High protein intake associates with cardiovascular events but not with loss of renal function.
Journal of the American Society of Nephrology : JASN 2009;20(8):1797-804.
2009: Rutger M van Ree; Aiko P J de Vries; Leendert H Oterdoom; Marc A Seelen; Ron T Gansevoort; Jan Schouten; Joachim Struck; gerjan navis; Reinold O B Gans; Jaap J Homan van der Heide; Willem J Van Son; Stephan J L Bakker
Plasma procalcitonin is an independent predictor of graft failure late after renal transplantation.
Transplantation 2009;88(2):279-87.
2009: Leendert H Oterdoom; Aiko P J de Vries; Rutger M van Ree; Ron T Gansevoort; Willem J Van Son; Jaap J Homan van der Heide; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
N-terminal pro-B-type natriuretic peptide and mortality in renal transplant recipients versus the general population.
Transplantation 2009;87(10):1562-70.
2009: Esther Meijer; Paul E de Jong; Eric J van der Jagt; D orienJ Peters; Martijn H Breuning; Ron T Gansevoort
[Autosomal dominant polycystic kidney disease: new insights and possible drugs].
Nederlands tijdschrift voor geneeskunde 2009;153(20):968-74.
2009: Bakhtawar K Mahmoodi; Ron T Gansevoort; Nic J G M Veeger; Abigail G Matthews; gerjan navis; Hans L Hillege; Jan van der Meer
Microalbuminuria and risk of venous thromboembolism.
JAMA : the journal of the American Medical Association 2009;301(17):1790-7.
2009: Hiddo J Lambers Heerspink; F L Nauta; C P van der Zee; Jacoline W Brinkman; Ron T Gansevoort; Dick De Zeeuw; S J L Bakker
Alkalinization of urine samples preserves albumin concentrations during prolonged frozen storage in patients with diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(5):556-9.
2009: Coen D A Stehouwer; Ron T Gansevoort
[Measurement of protein loss in the urine. A useful addition in cardiovascular disease risk assessment].
Nederlands tijdschrift voor geneeskunde 2009;153(17):796.
2009: Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?
Current hypertension reports 2009;11(2):111-7.
2009: Marije van der Velde; Nynke Halbesma; Frank T de Charro; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Screening for albuminuria identifies individuals at increased renal risk.
Journal of the American Society of Nephrology : JASN 2009;20(4):852-62.
2009: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Fasting insulin is a stronger cardiovascular risk factor in women than in men.
Atherosclerosis 2009;203(2):640-6.
2009: Ron T Gansevoort; Paul E de Jong
The case for using albuminuria in staging chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2009;20(3):465-8.
2009: Ron T Gansevoort; Eberhard Ritz
Hermann Senator and albuminuria--forgotten pioneering work in the 19th century.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(3):1057-62.
2009: Paul E de Jong; Ron T Gansevoort
Focus on microalbuminuria to improve cardiac and renal protection.
Nephron. Clinical practice 2009;111(3):c204-10; discussion c211.
2008: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(12):3851-8.
2008: Hiddo J Lambers Heerspink; Auke H Brantsma; Dick De Zeeuw; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
American journal of epidemiology 2008;168(8):897-905.
2008: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Extended prognostic value of urinary albumin excretion for cardiovascular events.
Journal of the American Society of Nephrology : JASN 2008;19(9):1785-91.
2008: Leendert H Oterdoom; Rutger M van Ree; Aiko P J de Vries; Ron T Gansevoort; Jan Schouten; Willem J Van Son; Jaap J Homan van der Heide; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients.
Transplantation 2008;86(3):391-8.
2008: Nynke Halbesma; Auke H Brantsma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Gender differences in predictors of the decline of renal function in the general population.
Kidney international 2008;74(4):505-12.
2008: Hiddo J Lambers Heerspink; Elsbeth C Witte; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw; Ron T Gansevoort
Screening and monitoring for albuminuria: the performance of the HemoCue point-of-care system.
Kidney international 2008;74(3):377-83.
2008: Cornelis Boersma; Maarten J Postma; Sipke T Visser; Jarir Atthobari; Paul E de Jong; Lolkje T W de Jong van den Berg; Ron T Gansevoort
Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events.
British journal of clinical pharmacology 2008;65(5):723-32.
2008: Paul E de Jong; Ron T Gansevoort
Fact or fiction of the epidemic of chronic kidney disease--let us not squabble about estimated GFR only, but also focus on albuminuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(4):1092-5.
2008: Maarten J Postma; Cornelis Boersma; Ron T Gansevoort
Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(4):1103-6.
2008: Esther Meijer; Paul E de Jong; Dorien J Peters; Ron T Gansevoort
Better understanding of ADPKD results in potential new treatment options: ready for the cure?
Journal of nephrology 2008;21(2):133-8.
2008: Paul E de Jong; Marije van der Velde; Ron T Gansevoort; Carmine Zoccali
Screening for chronic kidney disease: where does Europe go?
Clinical journal of the American Society of Nephrology : CJASN 2008;3(2):616-23.
2007: Ruud M A van de Wal; Pim van der Harst; Wim Gerritsen; Fal van der Horst; Thijs H W Plokker; Ron T Gansevoort; Wiek H van Gilst; Adriaan A Voors
Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2007;8(4):177-80.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of screening for cardio-renal risk factors on drug use in the general population.
British journal of clinical pharmacology 2007;64(6):810-8.
2007: Jacoline W Brinkman; Hiddo Lambers Heerspink; Dick De Zeeuw; Ron T Gansevoort; Stephan J L Bakker
Urinary pH affects albumin concentrations after prolonged frozen storage.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(12):3670.
2007: Annemieke Visser; Geke J Dijkstra; Roel M Huisman; Ron T Gansevoort; Paul E de Jong; Sijmen A Reijneveld
Differences between physicians in the likelihood of referral and acceptance of elderly patients for dialysis-influence of age and comorbidity.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(11):3255-61.
2007: Ron T Gansevoort; Heerspink Lambers; E C Witte
Methodology of screening for albuminuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2109-11.
2007: Jacoline W Brinkman; Dick De Zeeuw; Hiddo J Lambers Heerspink; Ron T Gansevoort; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Apparent loss of urinary albumin during long-term frozen storage: HPLC vs immunonephelometry.
Clinical chemistry 2007;53(8):1520-6.
2007: Paul E de Jong; Ron T Gansevoort; Stephan J L Bakker
Macroalbuminuria and microalbuminuria: do both predict renal and cardiovascular events with similar strength?
Journal of nephrology 2007;20(4):375-80.
2007: Wouter B A Eijkelkamp; Pieter A de Graeff; Dirk J van Veldhuisen; Richard P E van Dokkum; Ron T Gansevoort; Paul E de Jong; Dick De Zeeuw; Hans L Hillege
Effect of first myocardial ischemic event on renal function.
The American journal of cardiology 2007;100(1):7-12.
2007: Aminu K Bello; Dick De Zeeuw; Meguid El Nahas; Auke H Brantsma; Stephan J L Bakker; Paul E de Jong; Ron T Gansevoort
Impact of weight change on albuminuria in the general population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1619-27.
2007: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Fasting insulin modifies the relation between age and renal function.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1587-92.
2007: P E de Jong; Ron T Gansevoort; Jack F M Wetzels
[Population screening for urinary protein loss: a sensible action].
Nederlands tijdschrift voor geneeskunde 2007;151(19):1055-8.
2007: Jacobien C Verhave; Jack F M Wetzels; Stephan J L Bakker; Ron T Gansevoort
[Estimating renal function with formulas].
Nederlands tijdschrift voor geneeskunde 2007;151(18):1002-4.
2007: Yvonne de Kluizenaar; Ron T Gansevoort; Henk M E Miedema; Paul E de Jong
Hypertension and road traffic noise exposure.
Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine 2007;49(5):484-92.
2007: Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong van den Berg
The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate.
British journal of clinical pharmacology 2007;63(2):224-31.
2007: Auke H Brantsma; Jarir Atthobari; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
What predicts progression and regression of urinary albumin excretion in the nondiabetic population?
Journal of the American Society of Nephrology : JASN 2007;18(2):637-45.
2007: Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Determinants of insulin resistance in renal transplant recipients.
Transplantation 2007;83(1):29-35.
2007: Jacoline W Brinkman; Dick De Zeeuw; Ron T Gansevoort; Jacko J Duker; Ido P Kema; Paul E de Jong; Stephan J L Bakker
Prolonged frozen storage of urine reduces the value of albuminuria for mortality prediction.
Clinical chemistry 2007;53(1):153-4.
2007: Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Metabolic syndrome: a fata morgana?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):15-20.
2007: Rutger M van Ree; Leendert H Oterdoom; Aiko P J de Vries; Ron T Gansevoort; Jaap J Homan van der Heide; Willem J Van Son; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(1):246-53.
2006: Ruud M A van de Wal; Adriaan A Voors; Ron T Gansevoort
Urinary albumin excretion and the renin-angiotensin system in cardiovascular risk management.
Expert opinion on pharmacotherapy 2006;7(18):2505-20.
2006: Hiddo J Lambers Heerspink; Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Dick De Zeeuw
Update on microalbuminuria as a biomarker in renal and cardiovascular disease.
Current opinion in nephrology and hypertension 2006;15(6):631-6.
2006: Ruud M A van de Wal; Ron T Gansevoort; Pim van der Harst; Frans Boomsma; H W Thijs Plokker; Dirk J van Veldhuisen; Paul E de Jong; Wiek H van Gilst; Adriaan A Voors
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
Hypertension 2006;48(5):870-6.
2006: Jarir Atthobari; Auke H Brantsma; Ron T Gansevoort; Sipke T Visser; Folkert Asselbergs; Wiek H van Gilst; Paul E de Jong; Lolkje T W de Jong van den Berg
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3106-14.
2006: Ron T Gansevoort; Jacoline W Brinkman; Stephan J L Bakker; Paul E de Jong; Dick De Zeeuw
Evaluation of measures of urinary albumin excretion.
American journal of epidemiology 2006;164(8):725-7.
2006: Nynke Halbesma; Dirk-Sjoerd Kuiken; Auke H Brantsma; Stephan J L Bakker; Jack F M Wetzels; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
Journal of the American Society of Nephrology : JASN 2006;17(9):2582-90.
2006: Paul E de Jong; Nynke Halbesma; Ron T Gansevoort
Screening for early chronic kidney disease--what method fits best?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(9):2358-61.
2006: Jan Willem Haveman; Ron T Gansevoort; A H H Bongaerts; Maarten W N Nijsten
Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis.
Intensive care medicine 2006;32(8):1199-205.
2006: Paul E de Jong; Ron T Gansevoort
Prevention of chronic kidney disease: the next step forward!
Nephrology (Carlton, Vic.) 2006;11(3):240-4.
2006: Ron T Gansevoort; Stephan J L Bakker; Paul E de Jong
Early detection of progressive chronic kidney disease: is it feasible?
Journal of the American Society of Nephrology : JASN 2006;17(5):1218-20.
2006: Jarir Atthobari; Folkert Asselbergs; Cornelis Boersma; Robin de Vries; Hans L Hillege; Wiek H van Gilst; Ron T Gansevoort; Paul E de Jong; Lolkje T W de Jong van den Berg; Maarten J Postma
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
Clinical therapeutics 2006;28(3):432-44.
2006: Auke H Brantsma; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion as a predictor of the development of hypertension in the general population.
Journal of the American Society of Nephrology : JASN 2006;17(2):331-5.
2006: Aiko P J de Vries; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; gerjan navis; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker; Ron T Gansevoort
The predictive value of renal vascular resistance for late renal allograft loss.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2006;6(2):364-70.
2006: Patrick B Mark; Graham A Stewart; Ron T Gansevoort; Colin J Petrie; Theresa A McDonagh; Henry J Dargie; R Stuart C Rodger; Alan Jardine
Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(2):402-10.
2006: Cornelis Boersma; Jarir Atthobari; Ron T Gansevoort; Lolkje T W de Jong van den Berg; Paul E de Jong; Dick De Zeeuw; Lieven J P Annemans; Maarten J Postma
Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.
PharmacoEconomics 2006;24(6):523-35.
2005: Jacoline W Brinkman; Dick De Zeeuw; Jacko J Duker; Ron T Gansevoort; Ido P Kema; Hans L Hillege; Paul E de Jong; Stephan J L Bakker
Falsely low urinary albumin concentrations after prolonged frozen storage of urine samples.
Clinical chemistry 2005;51(11):2181-3.
2005: Paul E de Jong; Ron T Gansevoort
Screening techniques for detecting chronic kidney disease.
Current opinion in nephrology and hypertension 2005;14(6):567-72.
2005: Rutger M van Ree; Aiko P J de Vries; Leendert H Oterdoom; T Hauw The; Ron T Gansevoort; Jaap J Homan van der Heide; Willem J Van Son; Rutger J Ploeg; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2524-31.
2005: I A Huisman; Coen A Stegeman; Rijk O B Gans; Ron T Gansevoort
[Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
Nederlands tijdschrift voor geneeskunde 2005;149(42):2329-33.
2005: Auke H Brantsma; Stephan J L Bakker; Hans L Hillege; Dick De Zeeuw; Paul E de Jong; Ron T Gansevoort
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes.
Diabetes care 2005;28(10):2525-30.
2005: Leendert H Oterdoom; Aiko P J de Vries; Willem J Van Son; Jaap J Homan van der Heide; Rutger J Ploeg; Ron T Gansevoort; Paul E de Jong; Rijk O B Gans; Stephan J L Bakker
Validation of insulin resistance indexes in a stable renal transplant population.
Diabetes care 2005;28(10):2424-9.
2005: Stephan J L Bakker; Ron T Gansevoort; Erik M Stuveling; Rijk O B Gans; Dick De Zeeuw
Microalbuminuria and C-reactive protein: similar messengers of cardiovascular risk?
Current hypertension reports 2005;7(5):379-84.
2005: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
The association between atherosclerotic risk factors and renal function in the general population.
Kidney international 2005;67(5):1967-73.
2005: Ron T Gansevoort; Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population.
Kidney international. Supplement 2005;(94):S28-35.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Graham A Stewart; Ron T Gansevoort; Patrick B Mark; Esther Rooney; Theresa A McDonagh; Henry J Dargie; R Stuart; C Rodger; Alan Jardine
Electrocardiographic abnormalities and uremic cardiomyopathy.
Kidney international 2005;67(1):217-26.
2004: Ron T Gansevoort; Bart van der Heij; Coen A Stegeman; Frank T de Charro; Martin G Nieuwenhuizen; Dick De Zeeuw; Paul E de Jong
Trends in the incidence of treated end-stage renal failure in The Netherlands: hope for the future?
Kidney international. Supplement 2004;(92):S7-10.
2004: Jacoline W Brinkman; Stephan J L Bakker; Ron T Gansevoort; Hans L Hillege; Ido P Kema; Rijk O B Gans; Paul E de Jong; Dick De Zeeuw
Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC.
Kidney international. Supplement 2004;(92):S69-75.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Stephan J L Bakker; Dick De Zeeuw; Paul E de Jong
An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population.
Kidney international. Supplement 2004;(92):S18-21.
2004: Jacobien C Verhave; Hans L Hillege; Johannes G M Burgerhof; Wilbert M T Janssen; Ron T Gansevoort; gerjan navis; Dick De Zeeuw; Paul E de Jong
Sodium intake affects urinary albumin excretion especially in overweight subjects.
Journal of internal medicine 2004;256(4):324-30.
2004: Jacobien C Verhave; Ron T Gansevoort; Hans L Hillege; Dick De Zeeuw; Gary C Curhan; Paul E de Jong
Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function.
Journal of the American Society of Nephrology : JASN 2004;15(5):1316-22.
2004: Ron T Gansevoort; Paul E de Jong; Maarten J Postma
Cost-effectiveness of screening for proteinuria.
JAMA : the journal of the American Medical Association 2004;291(12):1442-3; author reply 1443.
2003: Patricia M Stassen; Bram E van Poelgeest; Kick J Bendel; Joop van Baarlen; Ron T Gansevoort
Quiz page. Xanthogranulomatous pyelonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(3):R48, E1-3.
2003: I A Huisman; C A Stegeman; P E de Jong; Ron T Gansevoort
[Clinical reasoning and decision-making in practice. A woman with hypokalaemia].
Nederlands tijdschrift voor geneeskunde 2003;147(12):551-5.
2001: Ron T Gansevoort; Roel M Huisman; M J de Jongste; I P Kema
[Determination of cardiac troponins for diagnosis 'acute myocardial infarct'].
Nederlands tijdschrift voor geneeskunde 2001;145(26):1273-4.
2000: Ron T Gansevoort; Dick De Zeeuw
The antihypertensive and renal effects of angiotensin II receptor antagonists: remaining questions.
Current opinion in nephrology and hypertension 2000;9(1):57-61.
1998: Frank G H van Der Kleij; Ron T Gansevoort; HG Kreeftenberg; WD Reitsma
Imported rickettsioses: think of murine typhus.
Journal of internal medicine 1998;243(2):177-9.
1997: Ron T Gansevoort; gerjan navis; F H Wapstra; Paul E de Jong; Dick De Zeeuw
Proteinuria and progression of renal disease: therapeutic implications.
Current opinion in nephrology and hypertension 1997;6(2):133-40.
1997: Frank G H van Der Kleij; gerjan navis; Ron T Gansevoort; J E Heeg; H Scheffer; Dick De Zeeuw; Paul E de Jong
ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12 Suppl 2():42-6.
1996: Ron T Gansevoort; N D Vaziri; Paul E de Jong
Treatment of anemia of nephrotic syndrome with recombinant erythropoietin.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(2):274-7.
1996: R P F Dullaart; Ron T Gansevoort; W J Sluiter; Dick De Zeeuw; Paul E de Jong
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment.
Metabolism: clinical and experimental 1996;45(6):723-30.
1996: M H Hemmelder; Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition.
Kidney international 1996;49(1):174-80.
1995: Ron T Gansevoort; W J Sluiter; M H Hemmelder; Dick De Zeeuw; Paul E de Jong
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(11):1963-74.
1995: Dick De Zeeuw; Ron T Gansevoort; Paul E de Jong
Losartan in patients with renal insufficiency.
The Canadian journal of cardiology 1995;11 Suppl F():41F-44F.
1995: Dick De Zeeuw; Ron T Gansevoort; R P F Dullaart; Paul E de Jong
Angiotensin II antagonism improves the lipoprotein profile in patients with nephrotic syndrome.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1995;13(1):S53-8.
1995: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10(4):497-504.
1994: Ron T Gansevoort; Dick De Zeeuw; S Shahinfar; A Redfield; Paul E de Jong
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1994;12(2):S37-42.
1994: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Kidney international 1994;45(3):861-7.
1994: Ron T Gansevoort; J E Heeg; F D Dikkeschei; Dick De Zeeuw; Paul E de Jong; R P F Dullaart
Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1994;9(3):244-50.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition.
Kidney international 1993;44(3):579-84.
1993: R P F Dullaart; Ron T Gansevoort; B D Dikkeschei; Dick De Zeeuw; Paul E de Jong; Arie Van Tol
Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
Kidney international 1993;44(1):91-7.
1993: Ron T Gansevoort; Dick De Zeeuw; Paul E de Jong
Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(1):202-6.
1992: Ron T Gansevoort; A J Apperloo; J E Heeg; P E de Jong; D de Zeeuw
The antiproteinuric effect of antihypertensive agents in diabetic nephropathy.
Archives of internal medicine 1992;152(10):2137-9.
1992: Ron T Gansevoort; F H Wapstra; J J Weening; Paul E de Jong; Dick De Zeeuw
Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis.
Nephron 1992;60(2):246-7.
1992: Ron T Gansevoort; J E Heeg; R Vriesendorp; Dick De Zeeuw; Paul E de Jong
Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1992;7 Suppl 1():91-6.